Skip to main content
OpenTrials

Clinical trial condition

Non-Small-Cell Lung Cancer

Explore clinical trials studying Non-Small-Cell Lung Cancer. Study availability and eligibility vary by location and protocol.

87 public trials 14 recruiting studies
Refine in advanced search Browse all conditions

Non-Small-Cell Lung Cancer trial results

Completed

Sasanlimab (PF-06801591, PD-1 Inhibitor) in Participants With Advanced Malignancies

NCT04181788

Conditions
Advanced Malignancies, Bronchial Neoplasms, Carcinoma, Bronchogenic, +9 more
Locations
  • Beijing Cancer hospital Beijing, Beijing Municipality, China
  • Chongqing Cancer Hospital Chongqing, Chongqing Municipality, China
  • Nanjing Drum Tower Hospital Nanjing, Jiangsu, China
  • Huashan Hospital Affiliated to Fudan University Shanghai, Shanghai Municipality, China
View all 49 locations
View Trial Details
Completed

Camrelizumab Combined With SRT/WBRT and Chemotherapy in Patients With Brain Metastases of Driven Gene-negative NSCLC

NCT04768075

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • Beijing Cancer Hospital Beijing, Beijing Municipality, China
  • Fujian Cancer Hospital Fujian, Fuzhou, China
  • Guangdong General Hospital Guangzhou, Guangdong, China
  • The First Affiliated Hospital of Guangzhou Medical University Guangzhou, Guangdong, China
View all 14 locations
View Trial Details
Completed

CAB-AXL-ADC Safety and Efficacy Study in Adults With NSCLC

NCT04681131

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • City of Hope - Duarte Duarte, California, United States
  • University of California Irvine Medical Center (UCIMC) - Chao Family Comprehensive Cancer Center Irvine, California, United States
  • California Research Institute Los Angeles, California, United States
  • USC Norris Los Angeles, California, United States
View all 60 locations
View Trial Details
Completed

First Time in Human Study of AZD8701 With or Without Durvalumab in Participants With Advanced Solid Tumours

NCT04504669

Conditions
Adenocarcinoma, Advanced Solid Tumours, Breast Diseases, +48 more
Locations
  • Research Site Baltimore, Maryland, United States
  • Research Site St Louis, Missouri, United States
  • Research Site Huntersville, North Carolina, United States
  • Research Site Franklin, Tennessee, United States
View all 13 locations
View Trial Details
Completed

Study to Assess the Safety and Tolerability of Repeated Doses of an Investigational New Drug in Patients With Cancer and Cachexia.

NCT04299048

Conditions
Anorexia, Atrophy, Body Weight, +39 more
Locations
  • Beverly Hills Cancer Center Beverly Hills, California, United States
  • SCL Health Cancer Centers of Colorado - St. Mary's Hospital and Regional Medical Center Grand Junction, Colorado, United States
  • Lutheran Medical Center Wheat Ridge, Colorado, United States
  • Tallahassee Memorial Healthcare Cancer Center Tallahassee, Florida, United States
View Trial Details
Completed

Phase II Trial of Continuation Therapy in Advanced NSCLC

NCT03083808

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • University of Illinois Cancer Center Chicago, Illinois, United States
  • Indiana University Melvin and Bren Simon Cancer Center Indianapolis, Indiana, United States
  • University of Iowa Hospital Clinics Iowa City, Iowa, United States
  • University of Minnesota Medcical Center Minneapolis, Minnesota, United States
View Trial Details

Related conditions